Digital platform-mediated ecosystem to accelerate the Immunoassay Interference Blocker Market at a CAGR of 6.7%
The immunoassay interference blocker-based market is expected to reach US$ 455 Mn by the end of 2031, with sales revenue expected to register 6.7% CAGR. …